Ameritas Investment Partners’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,649
| Closed | -$81K | – | 3272 |
|
|
2025
Q1 | $81K | Hold |
3,649
| – | – | ﹤0.01% | 1839 |
|
|
2024
Q4 | $72.2K | Hold |
3,649
| – | – | ﹤0.01% | 1972 |
|
|
2024
Q3 | $91.2K | Buy |
+3,649
| New | +$91.2K | ﹤0.01% | 1857 |
|
|
2024
Q2 | – | Sell |
-3,094
| Closed | -$61K | – | 3183 |
|
|
2024
Q1 | $61K | Hold |
3,094
| – | – | ﹤0.01% | 2034 |
|
|
2023
Q4 | $54.3K | Hold |
3,094
| – | – | ﹤0.01% | 2126 |
|
|
2023
Q3 | $53.7K | Buy |
3,094
+816
| +36% | +$14.2K | ﹤0.01% | 2059 |
|
|
2023
Q2 | $32.1K | Hold |
2,278
| – | – | ﹤0.01% | 2297 |
|
|
2023
Q1 | $24.5K | Hold |
2,278
| – | – | ﹤0.01% | 2386 |
|
|
2022
Q4 | $31.9K | Hold |
2,278
| – | – | ﹤0.01% | 2331 |
|
|
2022
Q3 | $29K | Hold |
2,278
| – | – | ﹤0.01% | 2323 |
|
|
2022
Q2 | $22K | Hold |
2,278
| – | – | ﹤0.01% | 2508 |
|
|
2022
Q1 | $23K | Hold |
2,278
| – | – | ﹤0.01% | 2495 |
|
|
2021
Q4 | $27K | Hold |
2,278
| – | – | ﹤0.01% | 2498 |
|
|
2021
Q3 | $26K | Hold |
2,278
| – | – | ﹤0.01% | 2559 |
|
|
2021
Q2 | $32K | Hold |
2,278
| – | – | ﹤0.01% | 2467 |
|
|
2021
Q1 | $42K | Hold |
2,278
| – | – | ﹤0.01% | 2187 |
|
|
2020
Q4 | $40K | Hold |
2,278
| – | – | ﹤0.01% | 2109 |
|
|
2020
Q3 | $35K | Buy |
2,278
+598
| +36% | +$9.19K | ﹤0.01% | 2052 |
|
|
2020
Q2 | $43K | Buy |
1,680
+705
| +72% | +$18K | ﹤0.01% | 1923 |
|
|
2020
Q1 | $15K | Hold |
975
| – | – | ﹤0.01% | 2335 |
|
|
2019
Q4 | $11K | Hold |
975
| – | – | ﹤0.01% | 2693 |
|
|
2019
Q3 | $8K | Hold |
975
| – | – | ﹤0.01% | 2810 |
|
|
2019
Q2 | $13K | Buy |
975
+440
| +82% | +$5.87K | ﹤0.01% | 2685 |
|
|
2019
Q1 | $10K | Hold |
535
| – | – | ﹤0.01% | 2695 |
|
|
2018
Q4 | $15K | Hold |
535
| – | – | ﹤0.01% | 2487 |
|
|
2018
Q3 | $14K | Buy |
+535
| New | +$14K | ﹤0.01% | 2689 |
|